US$ 23.03
incretin mimetics glp 1 agonists GLP-1 Analogues Incretins: History, Physiology, and Pharmacology
Description
Hospitals adoption of GLP-1 receptor agonists is driven by their ability to manage and treat diabetic patients with a variety of therapeutic options, from daily injections to newly available oral formulations

Retatrutide is an investigational medication not yet approved by the FDA

A., Khushaish, S., & Luqmani, Y

Incretins are gut hormones that stimulate insulin release from the pancreas when glucose rises in response to food ingestion

GLP-1 has a direct effect on adipose tissue
69705-5/asset/079012c9-a24f-4391-ba39-2f5d03668f6f/main.assets/gr1_lrg.jpg)